English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/50234
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Determination of viability of human cartilage allografts by a rapid and quantitative method not requiring cartilage digestion

AuthorsLópez, Carmen; Ajenjo, Nuria; Muñoz-Alonso, María J. ; Farde, Pilar; León, Javier ; Gómez-Cimiano, J.
Issue Date2008
PublisherCognizant Communication Corporation
CitationCell Transplantation 17(7): 859-864 (2008)
AbstractFresh osteochondral allograft transplantation is increasingly used for the treatment of cartilage pathologies of the knee. It is believed that transplantation success depends on the presence of viable chondrocytes in the graft, but methods to evaluate graft viability require the isolation of chondrocytes by enzymatic digestion of the cartilage and/or the use of radioactive precursors. We have adapted the well-known cell viability assay based on the reduction of tetrazolium derivatives to evaluate cartilage viability. We took advantage from the histological properties of cartilage tissue and the fact that some tetrazolium derivatives (e.g., WST-1, XTT) give soluble reduction products that can permeate the hyaline cartilage matrix. We have validated this assay in human cartilage explants from arthrotomy interventions and deceased donors, measuring the reduced product in the explant supernatant. Using this method we have compared the performance of several culture media in cartilage viability. From those tested, DMEM supplemented with fetal bovine serum results in higher viability of the cartilage and the explants remain viable at least 15 days in culture at 37°C. Cartilage cells continued expressing chondrocyte-specific genes, suggesting the maintenance of chondrogenic pheno-type. The described method offers a quantitative and convenient method to measure the viability of human cartilage grafts. Copyright © 2008 Cognizant Comm. Corp.
Identifiersdoi: 10.3727/096368908786516783
issn: 0963-6897
Appears in Collections:(IBBTEC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.